Hamel Lawrence G 4
4 · ACELRX PHARMACEUTICALS INC · Filed Sep 26, 2018
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Sale
Common Stock
2018-09-24$4.50/sh−6,953$31,289→ 35,011 total(indirect: By Trust)
Holdings
- 24,371
Common Stock
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.